Sort
21,281 grants matching “influenza”
Tumor antigen-decorated virus-like particles as a therapeutic cancer vaccine
$22,058Jaina Patel · Emory University · F31 · FY2014 · CA
RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VACCINE IN LAB WORKERS
$22,028University Of Iowa · M01 · FY2000 · RR
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
$21,877University Of California Los Angeles · F31 · FY2000 · AG
ROTAVIRUS AND NORWALK VIRUS
$21,500Bidadi V Venkataram Prasad · Baylor College Of Medicine · P41 · FY2010 · RR
NTHi Type IV pili: expression and vaccine potential
$21,438Robert S. Munson · Research Inst Nationwide Children'S Hosp · R01 · FY2008 · DC
Mitigating COVID-19 transmission in U.S. jails
$21,416Kyle Jeanne Popovich · Rush University Medical Center · R01 · FY2022 · AI
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac
$21,318Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · IP
Superantigen-Induced Vascular Injury and DIC
$21,202Jack J Hawiger · Vanderbilt University · R01 · FY2010 · HL
Immune Responses to Influenza Vaccination
$21,125Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2015 · HG
Identifying mechanisms of lung tissue-resident memory CD8 T cell decay
$21,039Sarah Louise Hayward · Emory University · F31 · FY2019 · HL
CXCR3, CCR5, BLT1 regulating effector CD8 cell migration
$21,012Shaza A Fadel · Massachusetts General Hospital · F32 · FY2007 · AI
Bilateral and Multilateral Activities
$20,936Fogarty International Center · Y01 · FY2010 · TW
Bilateral and Multilateral Activities
$20,936Fogarty International Center · Y01 · FY2011 · TW
Task B1C1: Vaccine and Treatment Evaluation Units (VTEU) Protocol Development and Implementation Natural History Challenge Study for Influenza
$20,850Justin Ortiz · University Of Maryland Baltimore · N01 · FY2024 · AI
2010 Red Raider Mini-Symposium: Mathematical Modeling in Population Biology and Epidemiology
$20,790Lih-Ing W Roeger · Texas Tech University · · FY2010 · MPS
Evaluation of Masks as a Source Control NPI
$20,724Donald K Milton · University Of Massachusetts Lowell · U01 · FY2007 · CI
INFLUENZA VACCINATION IN RENAL TRANSPLANT RECIPIENTS ON RAPAMYCIN
$20,535Camille Kotton · Massachusetts General Hospital · M01 · FY2006 · RR
PHASE II STUDY OF INTERLEUKIN 12 FOR PLATEAU PHASE MULTIPLE MYELOMA
$20,474Northwestern University · M01 · FY2000 · RR
Molecular Determinants of Cross-Reactive Antibody Response to Influenza in Humans
$20,128James E Crowe · Vanderbilt University Medical Center · R01 · FY2015 · AI
Superantigen-Induced Vascular Injury and DIC
$20,115Jack J Hawiger · Vanderbilt University · R01 · FY2009 · HL
CRYSTAL STRUCTURE DETERMINATION OF M2 PROTON CHANNEL
$20,098Runa Acharya · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2009 · RR
Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease
$20,079Susana Tejeda-Garibay · University Of California, Merced · F31 · FY2023 · HL
INFLUENZA IMMUNITY: UNIMMUNIZED CHILDREN BETWEEN 6 MONTHS AND 5 YEARS OF AGE
$20,047Stanford University · M01 · FY2005 · RR
Environmental Influences on Epigenetic Immune Programming
$20,032B. Paige Lawrence · University Of Rochester · R01 · FY2011 · ES
Defining the role of genetic drift in within-host influenza evolution
$20,018Katarina M Braun · University Of Wisconsin-Madison · F30 · FY2022 · AI